Zhejiang Huangma Technology Co.,Ltd (603181.SS)
Shaoxing, CN
Zhejiang Huangma Technology Co.,Ltd is a Chinese enterprise that focuses on the research, development, production, and distribution of surfactants and a variety of other chemical products. Established in 2003 and headquartered in Shaoxing, China, the company's offerings are integral to numerous industries. These include applications in new material resins, silicones, lubricants and metalworking fluids, environmentally friendly coatings, advanced composite materials, specialized fibers, and agrochemical additives.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.59% | -9.87% | -9.75% | -22.11% | -6.80% | -4.13% | +9.51% | +32.88% | +18.72% | +170.22% | +170.22% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+3.1% Q1'26: +8.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+8.6% Q1'26: +11.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+12.4% Q1'26: -11.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+20.8% ★ Q1'26: +19.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+13.4% ★ Q1'26: +12.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+1.1% Q1'26: +1.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.73× ★ Q1'26: 1.02× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.89B
est: 1.95B (-3.0%)
|
1.95B
est: 2.25B (-13.5%)
|
2.34B
est: 2.76B (-15.2%)
|
2.18B
est: 2.55B (-14.4%)
|
1.89B
est: 2.11B (-10.1%)
|
2.33B
est: 2.35B (-0.6%)
|
2.40B
est: 2.63B (-8.5%)
|
2.89B
2.76B – 3.01B
+9.8% YoY
|
3.35B
3.02B – 3.69B
+16.2% YoY
|
3.55B
3.29B – 3.82B
+5.9% YoY
|
| EBITDA |
341.72M
est: 398.49M (-14.2%)
|
352.21M
est: 459.41M (-23.3%)
|
417.06M
est: 562.28M (-25.8%)
|
427.00M
est: 520.44M (-18.0%)
|
442.27M
est: 745.11M (-40.6%)
|
540.85M
est: 829.94M (-34.8%)
|
632.25M
est: 929.71M (-32.0%)
|
1.02B
976.27M – 1.07B
+9.8% YoY
|
1.19B
1.07B – 1.31B
+16.2% YoY
|
1.26B
1.16B – 1.35B
+5.9% YoY
|
| EBIT |
265.02M
est: 307.90M (-13.9%)
|
268.47M
est: 354.98M (-24.4%)
|
332.10M
est: 434.46M (-23.6%)
|
335.47M
est: 402.13M (-16.6%)
|
332.47M
est: 588.72M (-43.5%)
|
417.95M
est: 655.75M (-36.3%)
|
499.65M
est: 734.58M (-32.0%)
|
806.51M
771.36M – 841.65M
+9.8% YoY
|
937.41M
843.44M – 1.03B
+16.2% YoY
|
992.99M
919.14M – 1.07B
+5.9% YoY
|
| Net Income |
256.16M
est: 247.30M (+3.6%)
|
320.26M
est: 303.72M (+5.4%)
|
448.40M
est: 426.19M (+5.2%)
|
477.14M
est: 482.87M (-1.2%)
|
324.73M
est: 365.25M (-11.1%)
|
397.78M
est: 425.74M (-6.6%)
|
436.61M
est: 447.26M (-2.4%)
|
577.21M
545.52M – 591.95M
+29.1% YoY
|
697.77M
603.45M – 733.17M
+20.9% YoY
|
683.58M
627.92M – 762.32M
-2.0% YoY
|
| SGA |
74.40M
est: 60.15M (+23.7%)
|
78.10M
est: 69.35M (+12.6%)
|
60.56M
est: 84.88M (-28.7%)
|
61.43M
est: 78.56M (-21.8%)
|
60.72M
est: 57.03M (+6.5%)
|
64.84M
est: 63.52M (+2.1%)
|
51.62M
est: 71.16M (-27.5%)
|
78.13M
74.72M – 81.53M
+9.8% YoY
|
90.81M
81.70M – 99.91M
+16.2% YoY
|
96.19M
89.04M – 103.34M
+5.9% YoY
|
| EPS |
0.44
est: 0.44 (+0.9%)
|
0.55
est: 0.53 (+2.9%)
|
0.77
est: 0.75 (+2.2%)
|
0.82
est: 0.85 (-3.5%)
|
0.57
est: 0.65 (-12.5%)
|
0.70
est: 0.68 (+2.9%)
|
0.76
est: 0.82 (-7.3%)
|
0.99
0.95 – 1.03
+20.7% YoY
|
1.16
1.05 – 1.28
+17.5% YoY
|
1.21
1.09 – 1.33
+4.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 310.7K | 0.39% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 192.4K | 0.28% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 123.3K | 0.29% |
| 4 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 13.2K | 0.46% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Qinghua Sun | Chief Financial Officer & Secretary | — | female |
| Wenya Xu | Accounting Supervisor | — | — |
| Xiakun Ma | Deputy GM & Director | — | male |
| Xinrong Wang | GM & Director | — | male |
| Yanan Chen | Head of Internal Audit Department & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603181.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
